rivoceranib,camrelizumab,sorafenib
bayer,jiangsu hengrui pharmaceuticals,elevar therapeutics,onyx
['sorafenib', 'hcc']
#hcc progress? cam/rivo vs sorafenib with improvement in os and pfs. primarily asian population. #esmo22 
GI Oncologist, focus pancreatic, biliary cancers, personalized tx’s. Love to dance, travel, and spend time with my family. ASCO FCOI: https://t.co/oXHqwAT6p6